Skip to main content
Livermore
Livermore
ZHEN

Rafferty Asset Management, LLC

SEC CIK
0001389426
Latest filing
Aug 14, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Rafferty Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by Rafferty Asset Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−180,471−100.0%Sold outHolders
Q1 2026180,471$7.26M<0.1%+9,015+5.3%AddedHolders
Q4 2025171,456$4.31M<0.1%+3,104+1.8%AddedHolders
Q3 2025168,352$3.81M<0.1%+24,500+17.0%AddedHolders
Q2 2025143,852$2.49M<0.1%−36,282−20.1%ReducedHolders
Q1 2025180,134$3.94M<0.1%−61,340−25.4%ReducedHolders
Q4 2024241,474$7.71M<0.1%+37,328+18.3%AddedHolders
Q3 2024204,146$5.89M<0.1%−37,836−15.6%ReducedHolders
Q2 2024241,982$9.28M<0.1%+93,181+62.6%AddedHolders
Q1 2024148,801$8.75M<0.1%+5,683+4.0%AddedHolders
Q4 2023143,118$8.57M<0.1%−71,043−33.2%ReducedHolders
Q3 2023214,161$8.15M<0.1%+121,893+132.1%AddedHolders
Q2 202392,268$8.41M<0.1%−17,130−15.7%ReducedHolders
Q1 2023109,398$7.22M<0.1%−54,706−33.3%ReducedHolders
Q4 2022164,104$8.49M0.1%+61,532+60.0%AddedHolders
Q3 2022102,572$7.01M0.1%+9,683+10.4%AddedHolders
Q2 202292,889$4.20M<0.1%−30,606−24.8%ReducedHolders
Q1 2022123,495$6.28M<0.1%−2,415−1.9%ReducedHolders
Q4 2021125,910$5.95M<0.1%+36,711+41.2%AddedHolders
Q3 202189,199$2.94M<0.1%+47,208+112.4%AddedHolders
Q2 202141,991$2.65M<0.1%−29,421−41.2%ReducedHolders
Q1 202171,412$3.06M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.